URINARY BLADDER NEOPLASMS
Clinical trials for URINARY BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Bladder cancer combo therapy trial halted early
Disease control TerminatedThis study tested whether adding the immunotherapy drug nivolumab to standard BCG treatment could help people with high-risk bladder cancer that came back after BCG alone. Only 13 people enrolled before the trial was stopped early. The goal was to see if the combination delayed c…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New bladder cancer treatment shows promise in early trial
Disease control TerminatedThis study tested a drug called enfortumab vedotin in 37 people with a type of bladder cancer that hasn't spread into the muscle wall. The drug was placed directly into the bladder using a thin tube. The main goals were to check for side effects and see if the drug could help tre…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Experimental drug combo shows promise against tough bladder cancer
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer treatments, in people with advanced or muscle-invasive bladder cancer. The goal was to see how safe the combinations were and whether they could shrink tumors. The study included 348 part…
Matched conditions: URINARY BLADDER NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 26, 2026 07:22 UTC